Microbiome-Targeted Therapeutics in Immunology
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Flares in gastrointestinal and dermatology indications are characterized by a shift in the proportion of bacterial species in either the gut or skin microbiome. This report focuses on the development of therapies targeting the skin microbiome for the treatment of acne, atopic dermatitis and psoriasis and on the development of therapies targeting the gut microbiome for the treatment of Crohn’s disease, ulcerative colitis, and irritable bowel syndrome.
Scope
GlobalData’s Microbiome-Targeted Therapeutics in Immunology combines key opinion leader and payer insight with in-house analyst expertise to provide an insight-rich look at the microbiome space in immunology.
Components of the report include:
• Overview of the Gut and Skin Microbiome – microbial dysbiosis by indication
• Epidemiology Overview – prevalent or diagnosed prevalent cases by indication for the 16MM
• Pipeline Assessment—promising late-stage products and early-stage pipeline by indication
• Key Players – leading industry companies by indication
• Clinical Trials Mapping and Design — trial breakdown by phase/indication and trial design by indication
• Fecal Microbiota Transplants—opportunities and challenges for gastrointestinal indications
• Pricing, Reimbursement and Regulatory Strategy – US payer perspective on late-stage therapies
• Market Outlook — market potential estimation of late-stage therapies and key launch dates
Reasons to Buy
Develop business strategies by understanding the trends shaping and driving the global microbiome market in immunology.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Gain insights to help plan and design your clinical trials.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Identify key pricing and reimbursement strategies.
Synthetic Biologics
4D Pharma
Enterome Bioscience
Second Genome
Seres Therapeutics
Rebiotix
Intrexon
Vedanta Biosciences
AOBiome
Matrisys Bioscience
SFA Therapeutics
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.